CA2107682A1 - Recepteurs de l'interleukine 8, molecules apparentees et methodes - Google Patents
Recepteurs de l'interleukine 8, molecules apparentees et methodesInfo
- Publication number
- CA2107682A1 CA2107682A1 CA002107682A CA2107682A CA2107682A1 CA 2107682 A1 CA2107682 A1 CA 2107682A1 CA 002107682 A CA002107682 A CA 002107682A CA 2107682 A CA2107682 A CA 2107682A CA 2107682 A1 CA2107682 A1 CA 2107682A1
- Authority
- CA
- Canada
- Prior art keywords
- receptor
- polypeptide
- leu
- binding
- ctg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68510191A | 1991-04-10 | 1991-04-10 | |
US07/685,101 | 1991-04-10 | ||
US72660691A | 1991-07-09 | 1991-07-09 | |
US07/726,606 | 1991-07-09 | ||
US80384291A | 1991-12-09 | 1991-12-09 | |
US07/803,842 | 1991-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2107682A1 true CA2107682A1 (fr) | 1992-10-11 |
Family
ID=27418452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002107682A Abandoned CA2107682A1 (fr) | 1991-04-10 | 1992-04-10 | Recepteurs de l'interleukine 8, molecules apparentees et methodes |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0579739A4 (fr) |
JP (1) | JPH06506596A (fr) |
CA (1) | CA2107682A1 (fr) |
WO (1) | WO1992018641A1 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767063A (en) * | 1991-03-29 | 1998-06-16 | Genentech, Inc. | Human IL-8 receptor and antibodies thereto |
US5840856A (en) * | 1991-03-29 | 1998-11-24 | Genentech, Inc. | Antibodies to a human PF4 superfamily receptor |
US5919896A (en) * | 1991-03-29 | 1999-07-06 | Genentech, Inc. | PF4A receptor |
US5543503A (en) * | 1991-03-29 | 1996-08-06 | Genentech Inc. | Antibodies to human IL-8 type A receptor |
US5440021A (en) * | 1991-03-29 | 1995-08-08 | Chuntharapai; Anan | Antibodies to human IL-8 type B receptor |
US6087475A (en) * | 1991-12-19 | 2000-07-11 | Genentech, Inc. | PF4A receptor |
JP3664176B2 (ja) * | 1992-11-10 | 2005-06-22 | ジェネンテック・インコーポレーテッド | C−c ckr−1,c−cケモカインレセプター |
EP0630405B1 (fr) * | 1992-11-17 | 1998-04-08 | Icos Corporation | Nouveau recepteur V28 du genre sept-transmembrane |
US6107475A (en) * | 1992-11-17 | 2000-08-22 | Icos Corporation | Seven transmembrane receptors |
US6448379B1 (en) * | 1993-09-14 | 2002-09-10 | Chiron Corporation | IL8 inhibitors |
AU1988795A (en) * | 1994-03-15 | 1995-10-03 | Repligen Corporation | Antibodies to interleukin-8 receptors and methods of use |
CA2242908A1 (fr) * | 1996-01-11 | 1997-07-17 | Human Genome Sciences, Inc. | Recepteur hsatu68 de la chemokine de la proteine g humaine |
US7888466B2 (en) | 1996-01-11 | 2011-02-15 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor HSATU68 |
US7081360B2 (en) * | 1998-07-28 | 2006-07-25 | Cadus Technologies, Inc. | Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties |
WO2004058189A2 (fr) * | 2002-12-24 | 2004-07-15 | The Board Of Regents Of The University Of Texas System | Antagonistes de la chimiokine et leurs utilisations |
WO2005052132A2 (fr) * | 2003-11-24 | 2005-06-09 | Exelixis, Inc | Utilisation de modulateurs de la morphogenese de ramification comme genes modificateurs de la morphogenese de ramification et leurs procedes d'utilisation |
WO2005103702A2 (fr) * | 2004-04-20 | 2005-11-03 | Bayer Healthcare Ag | Methodes diagnostiques et therapeutiques pour lutter contre les maladies associees au recepteur 2 de la chimiokine cxc (cxcr2) |
WO2006101439A1 (fr) * | 2005-03-23 | 2006-09-28 | Astrazeneca Ab | Criblage |
EP2718728A1 (fr) * | 2011-06-10 | 2014-04-16 | Université Libre de Bruxelles | Cibles et agents pour le traitement de la consolidation insuffisante des fractures osseuses |
RU2676317C1 (ru) * | 2017-08-30 | 2018-12-27 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) | ГЕНЕТИЧЕСКАЯ КОНСТРУКЦИЯ pCXCRs-Fc ДЛЯ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО СЛИТОГО БЕЛКА, ОБЛАДАЮЩЕГО АНТИ-IL-8 АКТИВНОСТЬЮ |
US11987816B2 (en) | 2018-04-02 | 2024-05-21 | Korea University Research And Business Foundation | Composition for inducing dedifferentiation from somatic cells to induced pluripotent stem cells and method of inducing dedifferentiation using same |
KR102049180B1 (ko) * | 2018-04-02 | 2019-11-26 | 고려대학교 산학협력단 | 체세포에서 유도 만능 줄기세포로의 역분화 유도용 조성물 및 이를 이용한 역분화 유도방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69231223T3 (de) * | 1991-03-29 | 2008-01-17 | Genentech, Inc., South San Francisco | Menschliche pf4a rezeptoren und ihre verwendung |
-
1992
- 1992-04-10 JP JP4509396A patent/JPH06506596A/ja active Pending
- 1992-04-10 WO PCT/US1992/002977 patent/WO1992018641A1/fr not_active Application Discontinuation
- 1992-04-10 CA CA002107682A patent/CA2107682A1/fr not_active Abandoned
- 1992-04-10 EP EP19920910198 patent/EP0579739A4/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JPH06506596A (ja) | 1994-07-28 |
EP0579739A4 (fr) | 1994-03-22 |
EP0579739A1 (fr) | 1994-01-26 |
WO1992018641A1 (fr) | 1992-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2107682A1 (fr) | Recepteurs de l'interleukine 8, molecules apparentees et methodes | |
US5426048A (en) | DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor | |
US6504023B1 (en) | DNA encoding type II IL-1 receptors | |
US7317090B2 (en) | Antibodies to Interleukin-4 receptors and uses thereof | |
US5256766A (en) | Recombinant thrombin receptor and related pharmaceuticals | |
JP3415162B2 (ja) | Il―13受容体ポリペプチド | |
US20090068737A1 (en) | Methods of inhibiting interleukin-17 receptor | |
US20030060616A1 (en) | Type II IL-1 receptors | |
EP1239043A2 (fr) | Protéine de fusion comprenant le récepteur du facteur de nécrose tumorale | |
EP0318296A2 (fr) | Récepteurs d'interleukine-1 | |
US8124099B2 (en) | Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells | |
JP2003533488A (ja) | 免疫抑制を達成するための組成物および方法 | |
US8759505B2 (en) | Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases | |
JP2003535037A (ja) | 炎症を治療する方法 | |
CZ208197A3 (en) | Side protein of human receptor for interleukin 1 | |
JPH09509826A (ja) | 活性化cd4▲上+▼t細胞の表層上のレセプターに対するリガンド(act−4−l) | |
SK8752000A3 (en) | Novel g protein-coupled receptor | |
JP2003517846A (ja) | 可溶性インターロイキン−20レセプター | |
JP2001526532A (ja) | オステオプロテゲリン結合性蛋白および受容体 | |
SK288287B6 (sk) | Protilátka proti sekvencii SEQ ID No: 1 alebo polypeptid s jej obsahom a ich použitie | |
IE63450B1 (en) | Leukemia inhibitory factor receptors | |
US9127086B2 (en) | CD31 peptides in the treatment of thrombotic and autoimmune disorders | |
US20110027263A1 (en) | Soluble interleukin-20 receptor | |
JPH025865A (ja) | ヒトの血小板由来の成長因子受容体 | |
US9102726B2 (en) | Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |